Citation Tools
PDFRegular and young investigator award abstracts
Clinical trials completed
303 Phase II trial of neoadjuvant nivolumab (Nivo) and intra-tumoral (IT) CMP-001 in high-risk resectable melanoma (Neo-C-Nivo): final results
Download to a citation manager
Download the citation for this article by clicking on one of the following citation managers:
- Cite this article as:
- 303 Phase II trial of neoadjuvant nivolumab (Nivo) and intra-tumoral (IT) CMP-001 in high-risk resectable melanoma (Neo-C-Nivo): final results